ArticleCureus2025
Emirates Society of Radiation Oncology (ESRO): Advancing Cancer Care in the UAE.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation oncology plays a crucial role in cancer treatment, with more than half of all cancer patients requiring radiotherapy at some stage. Despite rapid advancements in oncology services in the United Arab Emirates (UAE), the country has lacked a dedicated professional society for radiation oncology until now. The Emirates Society of Radiation Oncology (ESRO) was established in 2025 to address critical gaps in education, research, clinical practice, and policy advocacy within the field. This editorial highlights the rationale for ESRO's formation, including workforce training deficits, limited research collaboration, and the absence of unified clinical guidelines. ESRO aims to enhance professional development, foster multicenter research, advocate for evidence-based policy reforms, and standardize radiation oncology practices across the UAE. Through these efforts, ESRO seeks to elevate the quality of radiotherapy services, improve patient outcomes, and position the UAE as a key contributor to global advancements in radiation oncology. We call on all stakeholders, including oncologists, medical physicists, radiation therapists, policymakers, and healthcare institutions, to collaborate in realizing this vision for a stronger and more integrated radiation oncology community in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.